Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
122.6 USD | -0.59% | -1.32% | +27.13% |
Jun. 03 | Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to S&P 1000 | CI |
Jun. 03 | Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to S&P 400 - Biotechnology | CI |
Financials (USD)
Sales 2024 * | 1.94B | Sales 2025 * | 2.81B | Capitalization | 11.66B |
---|---|---|---|---|---|
Net income 2024 * | 307M | Net income 2025 * | 921M | EV / Sales 2024 * | 5.47 x |
Net cash position 2024 * | 1.03B | Net cash position 2025 * | 2.54B | EV / Sales 2025 * | 3.24 x |
P/E ratio 2024 * |
37.5
x | P/E ratio 2025 * |
11.8
x | Employees | 1,314 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.03% |
Latest transcript on Sarepta Therapeutics, Inc.
1 day | -0.59% | ||
1 week | -1.32% | ||
Current month | -5.60% | ||
1 month | -7.00% | ||
3 months | +0.83% | ||
6 months | +39.77% | ||
Current year | +27.13% |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 17-06-25 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 14-12-31 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 17-06-25 |
M. Wilsey
CHM | Chairman | 71 | 09-03-30 |
Richard Barry
BRD | Director/Board Member | 65 | 15-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.63% | 1 M€ | +0.84% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 122.6 | -0.59% | 1,636,235 |
24-06-07 | 123.3 | +5.01% | 1,485,701 |
24-06-06 | 117.4 | -1.96% | 1,283,601 |
24-06-05 | 119.8 | +0.06% | 1,795,025 |
24-06-04 | 119.7 | -3.63% | 1,125,314 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.13% | 11.66B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+93.29% | 9.17B |
- Stock Market
- Equities
- SRPT Stock